PMH17 COST-EFFECTIVENESS OF LONG ACTING METHYLPHENIDATE-OROS IN ADHD YOUTHS WITH SUBOPTIMAL SYMPTOM CONTROL ON IMMEDIATE-RELEASE METHYLPHENIDATE IN THE NETHERLANDS

Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63549-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)63549-8/fulltext
Title : PMH17 COST-EFFECTIVENESS OF LONG ACTING METHYLPHENIDATE-OROS IN ADHD YOUTHS WITH SUBOPTIMAL SYMPTOM CONTROL ON IMMEDIATE-RELEASE METHYLPHENIDATE IN THE NETHERLANDS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63549-8&doi=10.1016/S1098-3015(10)63549-8
First page :
Section Title :
Open access? : No
Section Order : 400
Categories :
Tags :
Regions :
ViH Article Tags :